Topic List : Cancer

  • Ovarian cancer mutations undertested

    A large study of women with breast and ovarian cancer has revealed significant gaps between national guidelines for genetic testing and actual testing practices, according to researchers from Stanford and five other institutions.


  • Colon cancer testing at 45 would avert deaths

    A Stanford-led study found that increasing the participation of older adults in colorectal cancer screening would help prevent more deaths than expanding testing to people in their 40s.


  • Immune cell-based cancer diagnostics

    Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.


  • Discovery could limit toxic effect of chemo

    Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.


  • Molecular data categorizes breast cancers

    Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.


  • Urine test for bladder cancer

    The researchers found that by testing for fragments of cancer DNA in urine, they could find the cancer in early stages of development, when it’s easier to treat.


  • CAR-T cells for pediatric solid tumors

    In mouse studies, a Stanford-led team has developed an engineered immune cell that eliminates several types of childhood tumors. The innovation may help patients with relapsed or metastatic disease.


  • Radiotherapy in less than a second

    SLAC and Stanford researchers have secured funding for two projects that share one goal: to reduce the side effects of radiation therapy by vastly shrinking the length of a typical session.


  • Understanding ‘chemo brain’

    Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.


  • No survival benefit with new cancer drug

    Cisplatin chemotherapy can bring lasting adverse health effects, but a new, presumably less-toxic alternative is not as effective at promoting survival, according to a large, Stanford-led trial.